MétaCan
Menu
← Back to cohort
Record W4246750892 · doi:10.21203/rs.3.rs-194998/v1

Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis

2021· preprint· en· W4246750892 on OpenAlexaff
Florence W. L. Tsui, Aifeng Lin, İ̇smail Sarı, Zhenbo Zhang, Hing Wo Tsui, Robert D. Inman

Bibliographic record

Venuenot available
Typepreprint
Languageen
FieldMedicine
TopicSpondyloarthritis Studies and Treatments
Canadian institutionsUniversity of TorontoQueen's UniversityUniversity Health Network
Fundersnot available
KeywordsOncostatin MInflammationLipocalinAxial spondyloarthritisMedicineAnkylosing spondylitisInternal medicineImmunologyInterleukin 6

Abstract

fetched live from OpenAlex

Abstract Background: Informative serum biomarkers for monitoring inflammatory activity and treatment responses in axial spondyloarthritis (axSpA) are lacking. We assessed whether Lipocalin 2 (LCN2) and Oncostatin M (OSM), both have roles in inflammation and bone remodeling, may accurately reflect chronic inflammation and treatment response in axSpA. Previous reports in animal models showed involvement of LCN2 and OSM in gut inflammation. We asked whether they also play a role in human axSpA.Methods. Analysis of a longitudinal observational axSpA cohort (286 patients) with yearly clinical assessments and concurrent measurements of serum LCN2 and OSM (1204 serum samples) for up to 12 years. Biomarkers levels were correlated with MRI scoring and treatment response. Results. Persistent and transient elevation of LCN2 and OSM were observed in axSpA patients. Persistent elevation of LCN2 or OSM, but not CRP, was correlated with sacroiliac joint MRI SPARCC scores (Pearson’s correlation p = 0.0005 and 0.005 for LCN2 and OSM respectively). We observed both concordant and discordant patterns of LCN2 and OSM in relationship to back pain, the cardinal clinical symptom in axSpA. 26% (73/286) of the patients remained both clinically and serologically active (CASA). 14% (40/286) of them remained clinically active with back pain, but were serologically quiescent (CASQ). 60% (173/286) of the patients became clinically quiescent, with back pain resolved, but 53% (92/173) of them were serologically active (CQSA). With respect to treatment responses, transient elevation of LCN2 or OSM over time was predictive of better response to all treatments. The data suggest that failure to normalize LCN2 and OSM indicates persistent chronic inflammation, as reflected by positive MRI imaging of the sacroiliac joints. Prevalence of severe ankyloses is comparable in CQSA and CASA patients, indicating that disease progresses even when back pain may be controlled (CQ)Conclusion. In axSpA, persistent LCN2 and/or OSM elevation reflects chronic SIJ inflammation and suboptimal treatment response. In our cohort, half of the currently deemed clinically quiescent patients with back pain resolved, continued to demonstrate chronic inflammation. LCN2 and OSM profiling outperforms CRP as a predictive measure and provides an objective assessment of chronic local inflammation in axSpA patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.319
Teacher spread0.284 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same topicSpondyloarthritis Studies and Treatments→French-language works237,207→